BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence

Association of the brain-derived neurotrophic factor (BDNF) genetic polymorphism rs6265 (Val66Met) with methamphetamine (METH) dependence and METH-induced psychosis was investigated in the Thai population. The rs6265 genotype was determined in 100 male METH-dependent subjects and 102 controls using...

Full description

Saved in:
Bibliographic Details
Published inPharmacogenomics Vol. 16; no. 14; pp. 1541 - 1545
Main Authors Iamjan, Sri-arun, Thanoi, Samur, Watiktinkorn, Paritat, Nudmamud-Thanoi, Sutisa, Reynolds, Gavin P
Format Journal Article
LanguageEnglish
Published England Future Medicine Ltd 01.09.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Association of the brain-derived neurotrophic factor (BDNF) genetic polymorphism rs6265 (Val66Met) with methamphetamine (METH) dependence and METH-induced psychosis was investigated in the Thai population. The rs6265 genotype was determined in 100 male METH-dependent subjects and 102 controls using a real-time PCR high-resolution melt (RT-PCR-HRM) assay. The rs6265 genotype demonstrated significant differences in distribution between METH-dependent subjects and controls in which the frequency of GG genotype versus A-allele carriers was associated with METH dependence. Moreover, a significant effect of genotype on the occurrence of psychosis was found, with a lower frequency of GG genotype associated with METH-induced psychosis. The present findings indicate that rs6265 is associated with METH dependence in the Thai population, with the GG genotype greater in METH-dependent subjects but reducing the emergence of METH-dependent psychosis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1462-2416
1744-8042
1744-8042
DOI:10.2217/pgs.15.96